BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20222047)

  • 1. Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer.
    Middeldorp A; Jagmohan-Changur SC; van der Klift HM; van Puijenbroek M; Houwing-Duistermaat JJ; Webb E; Houlston R; Tops C; Vasen HF; Devilee P; Morreau H; van Wezel T; Wijnen J
    Genes Chromosomes Cancer; 2010 Jun; 49(6):539-48. PubMed ID: 20222047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
    Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
    Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
    Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
    Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a colorectal cancer susceptibility locus on chromosome 3q21-q24 from a high-density SNP genome-wide linkage scan.
    Kemp Z; Carvajal-Carmona L; Spain S; Barclay E; Gorman M; Martin L; Jaeger E; Brooks N; Bishop DT; Thomas H; Tomlinson I; Papaemmanuil E; Webb E; Sellick GS; Wood W; Evans G; Lucassen A; Maher ER; Houlston RS;
    Hum Mol Genet; 2006 Oct; 15(19):2903-10. PubMed ID: 16923799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
    Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
    Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
    Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
    Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.
    Aaltonen L; Johns L; Järvinen H; Mecklin JP; Houlston R
    Clin Cancer Res; 2007 Jan; 13(1):356-61. PubMed ID: 17200375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
    Zhang YZ; Sheng JQ; Li SR; Wu ZT
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity and unmapped genes for colorectal cancer.
    Lewis CM; Neuhausen SL; Daley D; Black FJ; Swensen J; Burt RW; Cannon-Albright LA; Skolnick MH
    Cancer Res; 1996 Mar; 56(6):1382-8. PubMed ID: 8640829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.
    Aaltonen LA; Peltomäki P; Mecklin JP; Järvinen H; Jass JR; Green JS; Lynch HT; Watson P; Tallqvist G; Juhola M
    Cancer Res; 1994 Apr; 54(7):1645-8. PubMed ID: 8137274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GALNT12 is not a major contributor of familial colorectal cancer type X.
    Seguí N; Pineda M; Navarro M; Lázaro C; Brunet J; Infante M; Durán M; Soto JL; Blanco I; Capellá G; Valle L
    Hum Mutat; 2014 Jan; 35(1):50-2. PubMed ID: 24115450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
    Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
    Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMSH6 alterations in patients with microsatellite instability-low colorectal cancer.
    Parc YR; Halling KC; Wang L; Christensen ER; Cunningham JM; French AJ; Burgart LJ; Price-Troska TL; Roche PC; Thibodeau SN
    Cancer Res; 2000 Apr; 60(8):2225-31. PubMed ID: 10786688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the genetic background and tumour profiling in familial colorectal cancer.
    van Wezel T; Middeldorp A; Wijnen JT; Morreau H
    Mutagenesis; 2012 Mar; 27(2):239-45. PubMed ID: 22294773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary cancers after sporadic and familial colorectal cancer.
    Hemminki K; Li X; Dong C
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):793-8. PubMed ID: 11440965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer susceptibility quantitative trait loci in mice as a novel approach to detect low-penetrance variants in humans: a two-stage case-control study.
    Fernández-Rozadilla C; Tarrío R; Clofent J; de Castro L; Brea-Fernández A; Bessa X; Abulí A; Andreu M; Jover R; Xicola R; Llor X; Castells A; Castellví-Bel S; Carracedo A; Ruiz-Ponte C;
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):619-23. PubMed ID: 20142256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair.
    Boardman LA; Schmidt S; Lindor NM; Burgart LJ; Cunningham JM; Price-Troska T; Snow K; Ahlquist DA; Thibodeau SN
    Genes Chromosomes Cancer; 2001 Feb; 30(2):181-6. PubMed ID: 11135435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
    Mao X; Hamoudi RA; Talbot IC; Baudis M
    Cancer Genet Cytogenet; 2006 May; 167(1):1-14. PubMed ID: 16682279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.